# Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma

> **NCT01387724** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 300 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **GENETIC:** RNA analysis
- **GENETIC:** polymerase chain reaction
- **GENETIC:** protein expression analysis
- **GENETIC:** proteomic profiling
- **GENETIC:** western blotting
- **OTHER:** enzyme-linked immunosorbent assay
- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis
- **OTHER:** liquid chromatography
- **OTHER:** mass spectrometry

## Key facts

- **NCT ID:** NCT01387724
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2016-05
- **Final completion:** —
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2016-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01387724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01387724, "Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01387724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*